Why pandemic swine flu causes more severe symptoms than seasonal flu

London, September 11 (ANI): Scientists at Imperial College London have warned that pandemic swine flu can infect cells deeper in the lungs than seasonal flu can.

They write in a research paper that this may help understand why people infected with the pandemic strain of swine-origin H1N1 influenza are more likely to suffer more severe symptoms than those infected with the seasonal strain of H1N1.

The researchers have also stressed the need for monitoring the current pandemic H1N1 influenza virus for any changes in the way it infects cells, which may make infections more serious.

Generally, influenza viruses infect cells by attaching to bead-like molecules on the outside of the cell, known as receptors. If a virus cannot find its specific receptors, it cannot get into the cell.

Seasonal influenza viruses attach to receptors found on cells in the nose, throat and upper airway, enabling them to infect a person’s respiratory tract.

In the current study, the researchers have found that pandemic H1N1 swine flu can also attach to a receptor found on cells deep inside the lungs, which can result in a more severe lung infection.

They say that the pandemic influenza virus’s ability to stick to the additional receptors may explain why the virus replicates, and spreads between cells more quickly.

“Most people infected with swine-origin flu in the current pandemic have experienced relatively mild symptoms. However, some people have had more severe lung infections, which can be worse than those caused by seasonal flu. Our new research shows how the virus does this – by attaching to receptors mostly found on cells deep in the lungs. This is something seasonal flu cannot do,” Nature Biotechnology quoted Professor Ten Feizi, from the Division of Medicine at Imperial College London, as having writte in the research paper.

The researchers found that pandemic H1N1 influenza bound more weakly to the receptors in the lungs than to those in the upper respiratory tract, which is why most people infected with the virus have experienced mild symptoms.

However, the researchers are concerned that the virus could mutate to bind more strongly to these receptors.

“If the flu virus mutates in the future, it may attach to the receptors deep inside the lungs more strongly, and this could mean that more people would experience serious symptoms. We think scientists should be on the lookout for these kinds of changes in the virus so we can try to find ways of minimising the impact of such changes,” said Prof. Feizi.

“Receptor binding determines how well a virus spreads between cells and causes an infection. Our new study adds to our understanding of how swine-origin influenza H1N1 virus is behaving in the current pandemic, and shows us changes we need to look out for,” added Prof. Feizi.

The financial assistance for the study came from the Wellcome Trust, the Medical Research Council and the Engineering and Physical Sciences Research Council. (ANI)

Over-expressed protein may make non-invasive breast cancer invasive

Washington, Sep 9 (ANI): An over-expressed protein can convert active but non-invasive breast cancer into a different cell type, and thereby turn it into invasive breast cancer, according to scientists at The University of Texas M. D. Anderson Cancer Center.

The researchers say that overexpression of the protein 14-3-3? (zeta) launches a molecular cascade that removes bonds that tie the pre-malignant cells together, and hold them in place, converting them from stationary epithelial cells to highly mobile mesenchymal-like cells.

This epithelial-to-mesenchymal transition (EMT) is recognized as a crucial step in metastasis, the spread of cancer to distant organs that causes 90 percent of all cancer deaths.

“We have discovered a key molecular mechanism for the deadly transition of non-invasive breast cancer into invasive disease,” said senior author Dr. Dihua Yu.

The researchers have shown that the zeta protein teams up with the oncoprotein ErbB2, also known as HER2, in a two-hit process to convert normal mammary cells to invasive cancer cells.

The findings of the study also provided a biomarker in zeta to identify high-risk patients for more aggressive treatment before their noninvasive breast cancer converts to invasive disease.

The researchers also got new therapeutic targets among the components of the molecular pathway launched by zeta.

According to Yu, some drugs already aim at these targets.

In addition, they found a solution to a puzzling mystery about how a subset of non-invasive breast cancer with excessive presence of an ErbB2/HER2 develops into invasive breast cancer.

Earlier, the researchers showed that zeta is over-expressed in many other cancer types, like lung, liver, uterine, stomach cancers.

“Our findings might have broader implications relating to the mechanism of invasion and metastasis in other types of cancer,” Yu said.

The researchers said that it would be very challenging to target zeta by drugs because it also regulates other important proteins in normal cellular processes.

The study has been published in the journal Cancer Cell. (ANI)

Turning off oncogene may inhibit lung cancer stem cells’ growth

Washington, Sep 9 (ANI): A lung cancer oncogene, called PKCiota, is necessary for the proliferation of lung cancer stem cells, and turning it off could act as a key for the treatment of this deadly disease, according to scientists at the Mayo Clinic campus in Florida.

These stem cells are rare and powerful master cells that manufacture the other cells that make up lung tumours, and are resistant to chemotherapy treatment.

The study also shows that an agent, aurothiomalate, being tested at Mayo Clinic in a phase I clinical trial substantially inhibits growth of these cancer stem cells.

“Our data indicate that PKCiota is required for the earliest steps in the development of lung cancer, which is the expansion of tumor-initiating cells or cancer stem cells,” said the study’s senior author, Dr. Alan Fields.

“Lung cancer stem cells appear to be the major drivers in many common lung cancers, and in order for a therapeutic treatment to be effective, it has to disrupt these cancer stem cells. We show that aurothiomalate, the agent now being tested in lung cancer patients, can, in fact, target these cells,” he added.

While aurothiomalate was once used to treat rheumatoid arthritis, the researchers have now discovered that it can also target PKCiota.

Currently, the agent is being tested in patients at Mayo Clinic’s sites in Minnesota and Arizona and, based on this phase I trial, a phase II human clinical trial is planned to combine aurothiomalate with agents targeted at other molecules involved in cancer growth.

“We had previously shown that PKCiota is required to maintain tumor growth, but what this study sought to determine is whether PKCiota is involved in the initial steps of lung cancer development,” said Fields.

Fields said that, in mice, an oncogene known as Kras is thought to transform normal lung stem cells into cancer stem cells, thereby initiating lung cancer.

In the present study, the researchers established a strain of mice in which Kras can be activated at the same time that the PKCiota gene is inactivated.

They found that when the PKCiota gene is inactivated, Kras was unable to cause errant growth and expansion of lung stem cells in mice, the process that initiates tumour formation.

“What this told us is that Kras requires PKCiota to transform the lung stem cells and make them proliferate. In other words, PKCiota is downstream from Kras, and is necessary for Kras to initiate lung tumor formation,” said Fields.

After discovering that aurothiomalate disables PKCiota, the researchers tested whether this agent is effective against lung cancer that develops due to Kras mutation.

“The drug showed potent inhibitory effects on the Kras-dependent proliferation of lung cancer stem cells both in cell culture and in animals,” said Fields.

“That further suggests that a drug like aurothiomalate could have an effect on tumors that are dependent on either Kras or PKCiota for growth and survival, and that is potentially a lot of cancers.

Aurothiomalate appears to be one of the few drugs available that can effectively target these critical cancer stem cells. In the clinic, however, it is likely that aurothiomalate will be most effective when combined with other agents designed to target other tumor survival pathways,” he added.

The study has been published in Cancer Research. (ANI)

Novel minimally invasive surgery for treating spinal cancer patients

Washington, Sep 8 (ANI): Doctors at Toronto Western Hospital have come up with a new minimally invasive, outpatient spine surgical procedure for treating cancer that has spread to the spine.

It is believed that almost 40-50 percent of metastic cancers end up in the spine and the most common primary cancers to spread to the bones of the spine are breast and lung cancer.

Spinal tumours can drastically affect a patient’s quality of life and result in pain and reduced mobility.

A spinal tumour or a growth of any kind can impinge on nerves, leading to pain, neurological problems and sometimes paralysis.

The new procedure involves a small incision in the back (the size of a loonie) in order to remove the tumour and stabilize the damaged spine.

Other than providing a shorter recovery time, its benefits also include allowing patients to receive radiation treatment shortly after surgery.

Traditional surgical methods involve a longer and more painful recovery process, thus making patients to wait weeks before resuming radiation treatment.

The combination of surgery and radiation leads to better outcomes and quality of life. (ANI)

Website that can rank people’s chances of death

Washington, Aug 27 (ANI): Want to know the chances of your death in the near future along with its cause? Well, then log on to www.DeathRiskRankings.com.

The new website, developed by researchers and students at Carnegie Mellon University, allows users to query publicly available data from the United States and Europe, and compare mortality risks by gender, age, cause of death and geographic region.

The Web site not only gives the risk of dying within the next year, but it also ranks the probable causes and allows for quick side-by-side comparison between groups.

For example, if a person wanted to know who is more likely to die next year from breast cancer-a 54-year-old Pennsylvania woman or her counterpart in the United Kingdom.

“This is the only place to look. It turns out that the British woman has a 33 percent higher risk of breast cancer death. But for lung/throat cancer, the results are almost reversed, and the Pennsylvania woman has a 29 percent higher risk,” said Paul Fischbeck, site developer and professor of social and decision sciences and engineering and public policy (EPP) at Carnegie Mellon.

“Most Americans don’t have a particularly good understanding of their own mortality risks, let alone ranking of their relevant risks,” said David Gerard, a former EPP professor at Carnegie Mellon.

They found that beyond infancy, the risk of dying increases annually at an exponential rate.

A 20-year-old U.S. woman has a 1 in 2,000 (or 0.05 percent) chance of dying in the next year.

By 40 years of age, the risk is three times greater, by age 60, it is 16 times greater; and by age 80, it is 100 times greater (around 1 in 20 or 5 percent).

“The risks are higher, but still not that bad. At 80, the average U.S. woman still has a 95 percent chance of making it to her 81st birthday,” said Gerard.

The researchers are hoping that the new Web site will help bring focus to some of the discussion now raging over health care policy in the United States.

“It’s much easier to make a persuasive argument when you have the facts to back it up, and this site provides all sides with the facts. We believe that this tool, which allows anyone to assess their own risk of dying and to compare their risks with counterparts in the United States and Europe, could help inform the public and constructively engage them in the debate,” said Fischbeck. (ANI)

By 2015, 2 million people would die annually from tobacco-induced cancers

Washington, Aug 26 (ANI): By 2015, at least 2.1 million people will die each year because of tobacco-induced cancers, revealed The Tobacco Atlas, Third Edition.

Published by the American Cancer Society and World Lung Foundation, the Atlas has estimated that tobacco use kills some six million people each year (more than a third of whom will die from cancer), and drains 500 billion dollars annually from global economies.

The Atlas graphically displays how tobacco is devastating both global health and economies, especially in middle- and low-resource countries, and tracks progress and outcomes in tobacco control.

Not only the death toll due to tobacco-induced cancers will go around 2 million by 2015, the Atlas predicted that by 2030, 83 percent of these deaths will occur in low and middle-income countries.

However, unlike other cancer-causing agents, the danger of tobacco is completely preventable through proven public policies.

Major measures include tobacco taxes, advertising bans, smokefree public places, and effective health warnings on packages.

These cost-effective policies are among those included in the Framework Convention on Tobacco Control (FCTC), a global treaty endorsed by more than 160 countries, and recommended by the World Health Organization MPOWER policy package.

The Atlas revealed that the global economy lost a staggering 500 billion dollars due to tobacco use.

These economic costs come as a result of lost productivity, misused resources, missed opportunities for taxation, and premature death.

The Atlas revealed that in 2006, about 600 billion smuggled cigarettes made it to the market, representing an enormous missed tax opportunity for governments, as well as a missed opportunity to prevent many people from starting to smoke and encourage others to quit.

Tobacco replaces potential food production on almost 4 million hectares of the world’s agricultural land, equal to all of the world’s orange groves or banana plantations.

In developing countries, smokers spend disproportionate sums of money relative to their incomes that could otherwise be spent on food, healthcare, and other necessities.

The Tobacco Atlas established an undeniable trend-the tobacco industry has shifted its marketing and sales efforts to countries that have less effective public health policies and fewer tobacco control resources in place:

It predicted that in 2010, 72 percent of those who die from tobacco related illnesses would be in low- and middle-income countries.

It revealed that since 1960 global tobacco production has increased three-fold in low- and middle-resource countries while halving in high-resource countries.

“The Tobacco Atlas is crucial to helping advocates in every nation get the knowledge they need to combat the most preventable global health epidemic,” said Dr. John R. Seffrin, chief executive officer, American Cancer Society.

The Tobacco Atlas was unveiled at the LIVESTRONG Global Cancer Summit. (ANI)

How to make a lung

Washington, Aug 18 (ANI): Scientists from University of Pennsylvania have shed light on how lungs are developed in the body.

They have identified a tissue-repair-and-regeneration pathway in the human body, including wound healing that is essential for the early lung to develop properly.

The researchers have also discovered two molecules in this pathway, Wnt2 and Wnt2b that play a key role in early lung development.

“We wanted to know the answer to a seemingly simple question: What is required to generate the lung in mammals?” said senior author Dr Edward Morrisey, Associate Professor of Medicine and Cell and Developmental Biology at the University of Pennsylvania School of Medicine.

“Wnt molecules are important for lung growth and we think that some of the molecules in the Wnt pathway are needed to specify lung progenitor cells and if not enough cells are ‘told’ to make a lung, an animal develops a faulty, smaller organ or even no lung,” he added.

Understanding how a lung develops is important in treating or preventing a host of lung and pulmonary diseases in children.

In the developing embryo, the lung, pancreas, liver, thyroid, and stomach all come from the foregut region, which starts out looking like a long tube.

“These organs bud from this undifferentiated tube and go on to develop into specific tissue types. The lung is one of the last to bud off the foregut during development,” said Morrisey.

The team focused on the Wnt pathway to see where and when Wnt molecules were expressed along the foregut tube, even before the lung starts to become a recognizable organ.

They found that the Wnt proteins Wnt2 and Wnt2b are expressed in the cells surrounding the foregut, right where the lung will eventually form. When they are knocked out, the animals completely lacked lungs.

Morrisey surmised that Wnt2 and Wnt2b were required to specify the early progenitors for the lung in the foregut.

The Morrisey lab showed that activation of the Wnt pathway resulted in formation of lung progenitors in both the esophagus and stomach where they are normally excluded.

“The ability of Wnt to program esophagus and stomach endoderm to a lung fate points to the critical role this pathway plays in lung development and suggests the possible use of Wnt in generating lung epithelium from non-lung sources,” said Morrisey.

The findings are described this week in Developmental Cell. (ANI)

First swine flu death occurs in Bangalore, toll rises to 20

Bangalore/Pune, Aug 13 (ANI): Bangalore on Thursday reported its first swine flu death. A 26-year-old woman succumbed to the deadly swine flu virus taking the country’s swine flu death toll to 20.

According to sources, Rupa was admitted to the St. Philomina Hospital.

Earlier, a 75-year-old woman Bharti Goyal died in Pune’s KEM Hospital. Another nine-month-old boy Rutwik Kamle also died at the Sahyadri Munot Hospital.

On Wednesday, a 48-year-old had succumbed to swine flu in Pune. This death was reported from the Sassoon General Hospital at around 4:30 p.m.

Earlier, a 50-year-old Neeta Meghani and a 33-year-old died in the same hospital.

Earlier in the day, a doctor and a 29-year-old woman had succumbed to the deadly virus in Nashik and Pune respectively.

In Nashik, 38-year-old doctor Rupesh Gangurde died at the Nashik Civil Hospital at around 2:30 a.m. this morning.

In Pune, Shrawani Deshpande died due to bilateral pneumonia following severe lung infection caused by the H1N1 virus at around the same time. 2:30 a.m.

Deshpande, a resident of Kothrud area, died at the Sasoon General Hospital.

Other swine flu deaths have occurred in Ahmedabad, Vadodra, Thane, Chennai and Thiruvananthapuram and Mumbai. (ANI)

Infant dies of swine flu in Pune, toll rises to 18

Pune, Aug 13 (ANI): A nine-month-old baby succumbed to the deadly swine flu virus in Pune on Thursday taking the country’s swine flu death toll to 18.

According to sources, the infant, who was suffering from acute respiratory distress syndrome, died at the Sahyadri Munot Hospital.

On Wednesday, a 48-year-old had succumbed to swine flu in Pune. This death was reported from the Sassoon General Hospital at around 4:30 p.m.

Earlier, a 50-year-old Neeta Meghani and a 33-year-old died in the same hospital.

Earlier in the day, a doctor and a 29-year-old woman had succumbed to the deadly virus in Nashik and Pune respectively.

In Nashik, 38-year-old doctor Rupesh Gangurde died at the Nashik Civil Hospital at around 2:30 a.m. this morning.

In Pune, Shrawani Deshpande died due to bilateral pneumonia following severe lung infection caused by the H1N1 virus at around the same time. 2:30 a.m.

Deshpande, a resident of Kothrud area, died at the Sasoon General Hospital.

Other swine flu deaths have occurred in Ahmedabad, Vadodra, Thane, Chennai and Thiruvananthapuram and Mumbai. (ANI)

Fat people ‘more likely to die of swine flu’

London, July 16 (ANI): Here’s some bad news for fat folks: Overweight people are more likely to die of swine flu, says a new US study.

According to unpublished figures, which were reported at a recent meeting of the US Centers for Disease Control and Prevention in Atlanta, Georgia, 99 people who died in the early stages of the pandemic in the US, 45 per cent were obese.

Up till now, most of the individuals who have died from H1N1 swine flu have had an underlying health problem which weakened their ability to fend off the virus, reports New Scientist.

Among the conditions recognised as increasing the risk from flu are hypertension, diabetes, chronic lung obstruction and coronary disease. Now it may be time to add obesity to the list.

The figures surprised most flu researchers.

“In 40 years of studying flu, I have never heard anything about obesity,” says virologist John Oxford of Barts and The London School of Medicine and Dentistry, University of London. (ANI)

Prof Sabharwal murder accused acquitted by Nagpur session court

Nagpur, July 13 (ANI): All six Akhil Bharatiya Vidyarthi Parishad (ABVP) activists who were accused in the H S Sabharwal murder case were acquitted by a sessions court here today.

In its verdict, the court said it was acquitting all ABVP activists as the prosecution had failed to prove their involvement in the murder.

According to the lawyer of the accused, the court further noted that the prosecution had failed to file conclusive evidence to prove that the six were present at the murder site.

Professor. Sabharwal, the head of the political science department of Ujjain’s Madhav College, died on August 26 2006 from lung and rib injuries after being beaten up by ABVP activists.

He was trying to convince students about the need for postponing the college union elections. (ANI)

Severe COPD linked to cognitive impairment

Washington, July 8 (ANI): A new study by researchers at Mount Sinai School of Medicine has shown that severe chronic obstructive pulmonary disease (COPD) is associated with lower cognitive function in older adults.

COPD is caused by noxious particles or gas, most commonly from smoking, which trigger an abnormal inflammatory response in the lung.

In the study, researchers compared cognitive performance in over 4,150 adults with and without COPD and found that individuals with severe COPD had significantly lower cognitive function than those without, even after controlling for confounding factors such as comorbidities.

“Our findings should raise awareness that adults with severe COPD are at greater risk for developing cognitive impairment, which may make managing their COPD more challenging, and will likely further worsen their general health and quality of life,” said lead author of the study, William W. Hung, M.D., M.P.H., assistant professor at Mount Sinai School of Medicine.

Patients with COPD may experience periods of hypoxia-low oxygen levels-that might lead to brain abnormalities that could reduce cognitive capacity.

Alternatively, hypoxia may cause or exacerbate diseases that are characterized by cognitive impairment, such as Alzheimer’s disease.

The results were published in the July 15 issue of the American Journal of Respiratory and Critical Care Medicine. (ANI)

Expert says swine flu child toll will double in next year

Melbourne, July 2 (ANI): A leading expert on swine flu has warned that twice as many children will die of the disease in the next 12 months compared to the number of deaths from regular influenza.

Professor Robert Booy, however, said the number of deaths would still be fairly small – around 10 or 12 in a year.

Three to six children die every year from regular influenza. It (death from swine flu) can occur in a healthy child although most of them we believe will occur in a child with a problem, say a chronic heart problem, long-standing lung, kidney, liver (problems) or diabetes,” Professor Booy told ABC radio.

“The likelihood is with this virus we’ll see more of the small number of severe (cases) than we do normally.”

Yesterday a three-year-old Victorian boy with swine flu died. The family requested the boy’s medical history not be released.

Prof Booy is the co-director of the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases at The Children’s Hospital at Westmead in Sydney. (ANI)

Meet, the 11-month-old tot who’s kept alive by Viagra

London, July 1 (AN): Despite being given just a few weeks to live by doctors, a little boy with a serious heart condition has managed to survive, courtesy anti-impotence drug Viagra.

Little Alfie Oliver, who needs six doses of the drug every day, is set to celebrate his first birthday in two weeks.

Alfie was born with two of his main arteries reversed, and surgeons switched them when he was 16 days old.

During a second op at three months, he had a heart attack and was rushed to intensive care.

Parents Tracey, 26, and rail worker Rob, 28, were told that he was less likely to survive and were put in touch with a children’s hospice.

Medics diagnosed the incurable blood vessel disorder pulmonary hypertension, which hits only a handful of children in Britain each year.

They prescribed liquid Viagra to open up the vessels.

After the treatment, Alfie is doing well and learning to walk, although doctors have warned that he may one day require a heart and lung transplant.

“We were shocked when the doctors put him on Viagra as you don’t think of it as a drug for babies,” the Sun quoted Tracey, of York, as saying.

“We don’t mind though. We call it Alfie’s lifesaver.

“It makes people giggle when we tell them – but if it keeps our son alive then who cares. He is our little fighter,” she added. (ANI)

Jacko’s ex-wife wants full custody of kids

London, June 27 (ANI): Late Michael Jackson’s ex-wife Debbie Rowe is seeking full custody of the couple’s children.

The King of Pop passed away at the age of 50 on Thursday (June 25) after a cardiac arrest apparently caused by an overdose of painkillers.

Soon after his death Jackson’s elderly mum Katherine and Debbie were set to launch into a bitter fight for custody of his children.

While Katherine was looking after Prince Michael Jnr, 12, Paris, 11, and seven-year-old Prince Michael II in Los Angeles, Debbie had apparently signed away her parental rights in return for a house and a multi-million dollar lump sum.

Jackson family lawyer Brian Oxman said Katherine would probably care for them long-term.

“She loves them dearly,” British tabloid the Sun quoted him as saying.

However, Debbie-who is the mother of Prince Jnr and Paris-had told a friend that she wanted full custody of the youngsters, just two days before Jacko’s death.

The friend revealed: “Debbie threw a fit, saying she was sick of the way Michael was bringing the children up. She said she was going to go for full custody of them. She said she was quite prepared to go all the way and fight him in court for it.”

In fact, the kids’ nanny Grace Rwaramba could also end up caring for them.

Sources close to the Jackson family said Katherine will “fight tooth and nail” to stop Debbie getting the youngsters.

Debbie’s friend said: “She understands there will be a vicious legal battle and she knows Michael’s mother will not readily hand the kids over to her. But she is their natural mother and will do whatever it takes to get them back.”

Last December, Debbie, 50, went to lawyers after Jacko’s biographer claimed that the star was suffering from a chronic lung condition and had just months to live.

She asked for more access to her children, saying: “I’m their mother and they need me.”

And now that the ‘Thriller’ hit-maker is dead, the friend said that Debbie wants her kids back for good.

The pal added: “At Christmas she just wanted to re-establish contact with them. But now she wants full custody. Michael’s mother is almost 80, Debbie doesn’t want them to lose their father and then their grandmother.”

Prince Michael Jnr and Paris were born during Debbie’s three-year marriage to Jacko in the 1990s.

Prince Michael II – nicknamed “Blanket” – was born later to a surrogate mother. (ANI)

Battling TB could be possible by just ‘flipping a switch’ in immune response

Washington, June 23 (ANI): Fighting tuberculosis or other airborne pathogens could only be a matter of manipulating what is called the “switching time” in immune response, say researchers at Ohio State University.

They define ‘switching time’ as the point at which a highly regulated immune response gives way to powerful cells that specialize in fighting a specific invading bug.

For dealing with tuberculosis, the researchers are using mathematical modelling to determine whether a change to the natural switching time would result in a more effective immune response.

They are also analysing which parts of the immune response are most important to striking a balance between properly timing the switch and killing the microbe.

The complex modelling considers the huge assortment of cells and molecules at work in the human immune response to Mycobacterium tuberculosis, the microbe that causes TB.

The modelling suggests that the average switching time occurs about 50 days after tuberculosis invades the lung, which roughly coincides with clinical expectations that a skin test will turn up positive for TB between four and eight weeks after infection.

But, by that time, bacteria have settled in and are harder to kill, even with the more robust immune response.

The launch of the stronger immune response goes unnoticed in about 90 percent of infections Because TB is highly evolved and adapted to the human host.

With less adapted but virulent pathogens, on the other hand, an individual becomes acutely ill, and sometimes dies, when the switching time occurs.

Scientists say that the mathematical models that predict relationships and interactions in the immune response could guide planning for therapies that would be designed to either accelerate or slow the switching time, depending on the pathogen.

“A great problem in developing drugs and vaccines against airborne pathogens is this apparent bottleneck in the immune response and the inability to quickly and effectively eradicate microbes in the lung environment. Understanding that bottleneck is an important part of this paper, and brings new insight into how to override the problem with tuberculosis and other pathogens,” said Larry Schlesinger, a senior author of the study.

In this research, the scientists sought to determine what it would take to shorten the switching time and reduce the number of bacteria in the lung.

“If we could shorten the treatment for TB, that would be very powerful in breaking the transmission cycle,” said Schlesinger.

The researchers could use the precision of the modelling to simulate outcomes resulting from multiple tweaks to the values assigned to the various immune response activities.

The research is scheduled to appear in the online early edition of the Proceedings of the National Academy of Sciences. (ANI)

Natalie Cole ‘discharged from hospital’

Washington, May 26 (ANI): Singer Natalie Cole has reportedly been released from the hospital after undergoing a kidney transplant and is said to be recuperating.

Natalie, who suffered a kidney failure caused by hepatitis C, was discharged five days after her kidney transplant.

“Natalie is continuing to do well under the circumstances,” People quoted Natalie’s representative, as saying.

Sadly for Natalie, who had planned to attend a private family memorial service for her sister Carol “Cookie” Cole, who passed away following a battle with lung cancer, had to undergo the life-saving organ transplant on the very same day.

Meanwhile, Natalie is expected to spend the next three to four months recuperating and will reorganize her tour dates in support of her album Still Unforgettable. (ANI)

How to clean the air inside houses to reduce asthma, allergy symptoms

Washington, May 24 (ANI): Health experts say that having clean indoor air is crucial to managing symptoms among people with allergies and asthma.

The suggestion comes from Allergy and Asthma Network Mothers of Asthmatics (AANMA), the sole organization whose mission is to eliminate suffering and death due to asthma, allergies and related conditions.

The non-profit organization has even come up with five tips for spring-cleaning the air inside houses, which will make it lung friendly by reducing allergens and irritants.

These tips are:

1. Smoking: Ask family members or visitors not to smoke in your home.

2. Mold: Search under sinks, around tubs and showers, on windowsills and in laundry areas for any signs of dampness and mold. Track the source of water, plug it up and clean up visible mold. Purchase and use a dehumidifier in basement areas.

3. Air it out: Give your bedroom a thorough airing out-wash curtains, linens and bedspreads, and make sure to clean anywhere dust and allergens collect.

4. Use a HEPA vacuum: If you don’t have one already, consider getting a HEPA (High Efficiency Particulate Air) vacuum. These vacuums have special filters that keep dust and allergens from blowing back into the air in your home.

5. Replace HVAC filters: Replace your furnace filters before air-conditioning season. And since the filter that comes with your HVAC (heating, ventilating and air conditioning) system isn’t designed to help you breathe better (it simply keeps dust and debris from clogging parts of the system) look into a high-efficiency filter or an air-cleaning unit. (ANI)

Vitamin D may halt weakening of asthmatics’ lung function

Washington, May 21 (ANI): Researchers at the University of Pennsylvania have found that vitamin D may slow the progressive decline in asthmatics’ ability to breathe as a result of human airway smooth muscle (HASM) proliferation.

In their study, the researchers found that calcitriol, a form of vitamin D synthesized within the body, reduced growth-factor-induced HASM proliferation in cells isolated from both persons with asthma and from persons without the disease.

The proliferation is a part of process called airway remodeling, which occurs in many people with asthma, and leads to reduced lung function over time.

According to researchers, by slowing airway remodeling, the decline in breathing that leaves many asthmatics even more vulnerable when they suffer an asthma attack can be prevented.

“Calcitriol has recently earned prominence for its anti-inflammatory effects. But our study is the first to reveal the potent role of calcitriol in inhibiting ASM proliferation,” said Gautam Damera, Ph.D

The studies were carried out with cells from 12 subjects, and the researchers compared calcitriol with dexmethasone, a corticosteroid prescribed widely for the treatment of asthma.

Although, dexmethasone is also a powerful anti-inflammatory agent, the researchers found that it had little effect on HASM growth.

Damera and his colleagues found calcitriol inhibits HASM in a dose-dependent manner.

They also conducted experiments to determine the mechanism by which calcitriol retards HASM proliferation.

They believe the vitamin works by inhibiting activation of distinct set of proteins responsible for cell-cycle progression.

The study has been presented at the American Thoracic Society’s 105th International Conference in San Diego on Wednesday, May 20. (ANI)

Childhood exposure to tobacco smoke may lead to early emphysema later

Washington, May 20 (ANI): Constant exposure to tobacco smoke puts kids at a higher risk of developing early emphysema later in life, say researchers.

“Emphysematous ‘holes’ in the lung that begin as small areas of damage or impaired development may expand according to a fractal trajectory after an earlier insult,” said Dr Gina Lovasi, of Columbia University.

“We hypothesized that environmental tobacco smoke in childhood may be one such early insult, associated with signs of early emphysema detectable on computed tomography (CT) scan in adulthood and perhaps lower lung function detectable by spirometry,” Lovasi added.

To determine whether chronic exposure to environmental tobacco smoke (ETS) in childhood could lead to the development of early emphysema, the researchers analyzed 1,781 adults who had never smoked from Multi-Ethnic Study of Artherosclerosis (MESA).

The CT images showed that some of the areas of lungs had indications of early emphysema: large contiguous areas of air-like density (“holes”, in contrast to lung tissue, which is more dense than air) or the total percentage of lung volume with air-like density.

The researchers found that non-smokers exposed to ETS in childhood more likely to have CT patterns that looked like early emphysema.

“The take-home message from our analysis is that exposure to tobacco smoke during childhood may be associated with detectable differences in lung structure, and perhaps early emphysema, later in life among people who do not themselves smoke,” said Lovasi.

“These findings might also help researchers to understand how lung damage develops,” Lovasi added. (ANI)